Skip to main content
Diagnostic Medical Systems logo

Diagnostic Medical Systems — Investor Relations & Filings

Ticker · ALDMS ISIN · FR0012202497 LEI · 969500RKTIGCNNIKIN19 PA Manufacturing
Open in API
Filings indexed 232 across all filing types
Latest filing 2017-05-12 Earnings Release
Country FR France
Listing PA ALDMS

About Diagnostic Medical Systems

https://www.dms.com/en/home/

Diagnostic Medical Systems (DMS) specializes in the development, design, and manufacturing of medical imaging systems. The company's core focus is on digital radiology and bone densitometry. Its product portfolio includes radiography and fluoroscopy systems, mobile x-ray units, surgical C-arms, and bone densitometers. DMS is engaged in developing next-generation imaging solutions aimed at improving patient care and personalized medicine. Key development projects include new mobile and surgical imaging equipment and an advanced range of bone densitometers for diagnosing and monitoring pathologies affecting bone mineral density.

Recent filings

Filing Released Lang Actions
Bon début d'exercice 2017 : chiffre d'affaires du 1er trimestre en progression de +9% à périmètre comparable - Solide performance de la division DMS Imaging, en croissance trimestrielle de +11%
Earnings Release Classification · 98% confidence The document is titled with a date (12/05/2017) and a headline announcing 'chiffre d'affaires du 1er trimestre en progression' (First quarter revenue in progress). It presents consolidated, unaudited IFRS data for Q1 2017 versus Q1 2016, detailing revenue by division. This structure is characteristic of an initial announcement of periodic financial results, focusing on key figures rather than a comprehensive report. This aligns perfectly with the definition of an Earnings Release (ER). It is not a full Annual Report (10-K) or a comprehensive Interim Report (IR), as it explicitly covers only the first quarter and is presented as a summary release. Q1 2017
2017-05-12 French
DMS Biotech signe un nouvel accord de distribution en Thaïlande pour ses solutions de lipofilling
M&A Activity Classification · 99% confidence The document is a press release dated May 9, 2017, announcing a new distribution agreement in Thailand for DMS Biotech's lipofilling solutions. It details the terms of the agreement (5 years, minimum revenue guarantee) and provides background on the technology and the strategic importance of the Thai market. It also includes a standard 'About DMS Group' section and contact information. This type of announcement, focusing on a specific business development (distribution agreement, revenue projection) that is not a mandatory periodic financial filing (like 10-K or IR) or a general earnings release (ER), fits best under the general category for regulatory announcements or significant corporate news that doesn't have a more specific code. Since it is a specific corporate announcement that is not a standard financial report, dividend notice, management change, or capital action, the most appropriate general category is Regulatory Filings (RNS), which serves as a fallback for significant, non-standard corporate news releases.
2017-05-09 French
Précision sur le nombre d'actions composant le capital social de DMS Group
Share Issue/Capital Change Classification · 99% confidence The document is a short press release dated 02/05/2017, titled "Précision sur le nombre d'actions composant le capital social de DMS Group" (Clarification on the number of shares comprising the share capital of DMS Group). It corrects an error regarding the market capitalization and explicitly states the current number of shares (15,593,159). It also announces the next event: the publication of Q1 2017 revenue on May 12, 2017. Since the document is short (3112 chars) and primarily serves to disseminate a specific, immediate piece of corporate information (share count correction and next event announcement) rather than being a comprehensive report (like 10-K or IR), it fits best as a general regulatory announcement or a specific update. Given the content focuses on capital structure details (share count) and upcoming results, it is closely related to capital/financing updates or general regulatory news. However, the core function here is a correction/clarification of a key corporate metric (share count) and an announcement of future results. It is not a formal report (10-K, IR), a dividend notice (DIV), or a director's dealing (DIRS). It is most appropriately classified as a general regulatory filing (RNS) or potentially a Capital/Financing Update (CAP) due to the focus on share count and market cap. Since it's a correction/clarification distributed via a news service (implied by the footer), RNS is the most suitable general category for non-standard, immediate disclosures that aren't covered by more specific codes like DIV or DIRS. It is not an announcement of a report publication (RPA) because it *is* the information, not just announcing that a report is available.
2017-05-02 French
Rapport financier annuel 2016
Annual Report Classification · 100% confidence The document is a comprehensive 'Rapport Financier Annuel' (Annual Financial Report) for DMS Group for the fiscal year ending December 31, 2016. It contains the management report, consolidated financial statements, and audit references. While it is a full annual report, the provided filing categories include '10-K' as the standard for Annual Reports. The document is clearly the full report itself, not an announcement or a summary, and contains substantive financial data. FY 2016
2017-04-28 French
Mise à disposition du rapport financier annuel 2016
Report Publication Announcement Classification · 99% confidence The document is dated April 28, 2017, and its primary subject is the 'Mise à disposition du rapport financier annuel 2016' (Making available of the 2016 annual financial report). It explicitly states that the annual financial report for the year ended December 31, 2016, has been made available to the public and filed with the AMF (Autorité des marchés financiers). Crucially, the document itself is very short (3595 characters) and serves only to announce that the full report is available on the company website ('Le rapport financier annuel peut être consulté sur le site internet de la société...'). According to Rule #2 (The 'MENU VS MEAL' Rule), a short announcement stating a report has been published points to a Report Publication Announcement (RPA), not the full report itself (which would likely be classified as 10-K if it were the full content).
2017-04-28 French
DMS Group et Fujifilm Europe concluent deux accords commerciaux et industriels en imagerie médicale et ostéodensitométrie
Regulatory Filings Classification · 95% confidence The document is titled "Communiqué de presse" (Press Release) dated 02/03/2017. It announces two commercial and industrial agreements between DMS Group and Fujifilm Europe regarding medical imaging and bone densitometry solutions. This type of announcement, detailing strategic business developments, partnerships, and product integration, is characteristic of a general corporate announcement rather than a formal regulatory filing like a 10-K, an earnings release (ER), or a specific financial report (IR, AR). Since it is a press release announcing business developments and not a specific regulatory filing type listed (like DIRS, DIV, CAP, etc.), and it is not merely announcing the publication of another report (RPA), the most appropriate general category for a significant, non-standard corporate announcement is Regulatory Filings (RNS), which serves as a broad category for miscellaneous official communications.
2017-03-02 French

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.